Human OGG1 Knockout Cell Line-HEK293T

Human OGG1 Knockout Cell Line-HEK293T

Cat.No. : CSC-RT2740

Host Cell: HEK293T Target Gene: OGG1

Size: 1x10^6 cells/vial, 1mL Validation: Sequencing

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Cat. No. CSC-RT2740
Cell Line Information This cell is a stable cell line with a homozygous knockout of human OGG1 using CRISPR/Cas9.
Target Gene OGG1
Host Cell HEK293T
Size Form 1 vial (>10^6 cell/vial)
Shipping Dry ice package
Storage Liquid Nitrogen
Species Homo sapiens (Human)
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Media Type Cells were cultured in DMEM supplemented with 10% fetal bovine serum.
Growth Properties Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6.
Freeze Medium Complete medium supplemented with 10% (v/v) DMSO
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Inquiry

Background

Case Study

Applications

OGG1, also known as oxoguanine glycosylase, is a key gene that encodes the enzyme responsible for excising 8-oxoguanine (8-oxoG) from DNA. 8-oxoG is a mutagenic base byproduct generated by exposure to reactive oxygen species (ROS) that, if not repaired, can lead to mutations. OGG1 plays an important role in the base excision repair pathway, a key mechanism for maintaining genomic integrity in a variety of organisms, including humans, bacteria, archaea, and other eukaryotes. The activity of OGG1 is regulated by oxidative stress. Under stress, OGG1 may be temporarily inactivated, which results in increased recruitment of transcription factors such as NFkB, which stimulates the expression of inflammatory genes. This suggests that OGG1 plays a role not only in genome maintenance, but also in the regulation of inflammatory responses. Studies have shown that mice lacking OGG1 have increased levels of 8-oxo-dG in both nuclear and mitochondrial DNA. These mice are also more susceptible to obesity, insulin resistance, and a higher incidence of cancer, especially when the MTH1 gene is also disrupted.

The onset of inflammation is associated with reactive oxygen species and oxidative damage to macromolecules such as 7,8-dihydro-8-oxoguanine (8-oxoG) in DNA. Since 8-oxoguanine DNA glycosylase 1 (OGG1) binds to 8-oxoG and Ogg1-deficient mice are resistant to acute and systemic inflammation, the researchers hypothesized that OGG1 inhibition may represent a strategy to prevent and treat inflammation. They developed TH5487, a selective OGG1 active site inhibitor that blocks OGG1 binding to and repair of 8-oxoG and is well tolerated by mice. TH5487 prevents tumor necrosis factor α-induced OGG1-DNA interactions at guanine-rich pro-inflammatory gene promoters. This in turn reduces nuclear factor κB DNA occupancy and pro-inflammatory gene expression, leading to reduced immune cell recruitment in the lungs of mice. Thus, they present a proof of concept that targeting oxidative DNA repair could alleviate inflammatory conditions in vivo.

For OGG1 inhibitors to exert pharmacological effects, they need to bind to OGG1 in cells and inhibit its activity. TH5487 increased the melting temperature of OGG1 in human cells (Figure 1A), indicating that TH5487 binds to its target in living cells and protects it from thermal denaturation. In addition, TH5487 also impaired KBrO3-induced genomic 8-oxoG repair. TH5487 caused a significant increase in genomic 8-oxoG after 2.5 hours (Figure 1B and C), and after 24 hours, 50 ± 8% of 8-oxoG remained in TH5487-treated cells (Figure 1C) without disrupting proliferation. Therefore, both genomic 8-oxoG and TH5487 are well tolerated by cells. Treatment with TH5487 increased the nuclear mobility of OGG1-GFP at 3 and 5 h after KBrO3 exposure (Figure 1D and E), indicating that TH5487 prevents OGG1 from binding to its genomic substrates in living cells. In addition, OGG1 knockout HEK293T cell showed reduced induction of CXCL1 [chemokine (C-X-C motif) ligand 1] mRNA after tumor necrosis factor-α (TNFα) stimulation (Figure 1F). Treatment with 5 μM TH5487 reduced CXCL1 expression by more than 50% in wild-type cells but not in OGG1 knockout HEK293T cells (Figure 1F). Therefore, this compound can be used to specifically inhibit OGG1-dependent proinflammatory gene expression.

Figure 1. TH5487 engages OGG1 in cells, inhibits DNA repair, and alters OGG1 chromatin dynamics.Figure 1. TH5487 engages OGG1 in cells, inhibits DNA repair, and alters OGG1 chromatin dynamics. (Visnes T, et al., 2018)

Cancer Research: The Human OGG1 Knockout Cell Line - HEK293T is widely used in cancer research to study the role of oxidative DNA damage in cancer development. By knocking out the OGG1 gene, researchers can study how the loss of OGG1 affects cell proliferation, mutation rates, and overall cancer progression. DNA Repair Mechanisms: This cell line is essential for studying DNA repair mechanisms, specifically base excision repair (BER). OGG1 is a key enzyme in the BER pathway, responsible for repairing 8-oxoguanine damage caused by oxidative stress. By using a knockout version of OGG1, scientists can better understand how cells compensate for the loss of this repair enzyme and identify other proteins and pathways involved in maintaining genomic integrity. Neurodegenerative Disease Research: The OGG1 gene has been implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. The Human OGG1 Knockout Cell Line - HEK293T provides a model to study how oxidative DNA damage contributes to neuronal cell death and the progression of neurodegenerative diseases. This could help identify potential biomarkers and therapeutic targets for these diseases. Drug Screening: This cell line can be used in high-throughput drug screening assays to identify compounds that modulate oxidative DNA damage and repair. By comparing the effects of candidate drugs on OGG1 knockout cells and wild-type cells, researchers can identify drugs that enhance or inhibit the DNA repair process, thereby aiding the development of new drugs for the treatment of various diseases associated with oxidative stress. Aging Research: Oxidative DNA damage is a major factor in the aging process. The human OGG1 knockout cell line - HEK293T allows resea rchers to study how OGG1 loss affects cellular aging.

For research use only. Not intended for any clinical use.
CBpromise   

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x